Pawel Szurnicki, MD
Gastroenterology · Columbia, MONPI 1164829636
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (59.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 51.0% of the total. Reporting peaked in 2023 at $2,710 and has fallen 99.3% since, to $20 in 2025.
Across 67 payments — averaging $105.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Olympus Corporation Of The Americas$2K
- AbbVie$306
- Johnson & Johnson$292
- Gilead$222
- Sanofi$145
- plus $510 from 8 others
What the payments were for
- Travel & lodging$4,21659%
- Food & beverage$2,79639%
- Education$841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $3,619 |
| Olympus Corporation Of The Americas | 18 | $2,000 |
| AbbVie | 6 | $306 |
| Johnson & Johnson | 3 | $292 |
| Gilead | 3 | $222 |
| Sanofi | 1 | $145 |
| Cook Medical LLC | 3 | $133 |
| E.r. Squibb & Sons, L.L.C. | 1 | $117 |
| 3-d Matrix, Inc. | 1 | $73 |
| Lilly USA, LLC | 1 | $72 |
| Olympus America Inc. | 3 | $59 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Steris Corporation | 1 | $19 |
| Shionogi Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Single Use Electrosurgical Knife KD-655$1,650
- DISPOSABLE DISTAL ATTACHMENT$1,650
- VISIGLIDE$1,050
- Olympus$1,050
- Resolution 360 Clip$951
- Single Use Aspiration Needle NA-U200H$545
- DUPIXENT$145
- EXALT Model D$141
- Creon$123
- ZEPOSIA$117
- STELARA$110
- Instinct$105
- Rinvoq$104
- Epclusa$100
How this compares
$7,096 in reported general payments places this provider in the 75th percentile of 374 gastroenterology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $160 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Columbia
- Bradley AndersonColumbia$194K
- Michael WilliamsColumbia$52K
- Yezaz GhouriColumbia$32K
- Gregory SayukSaint Louis$1.1M
- Katie SchroederSaint Louis$730K
- David AlpersSaint Louis$616K
- Kamran QureshiLake St Louis$279K
- Laith Al MomaniKansas City$249K
- Ahmed SaeedKansas City$246K
- Parakkal DeepakSaint Louis$205K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.